COMMUNIQUÉS West-GlobeNewswire

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
03/12/2025
KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) ("BGLC" or the "Company"), a biotechnology company advancing precision diagnostics and gene-based technologies, today [...]
Key Narmafotinib Patent Granted in the U.S.
03/12/2025
Highlights The Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent for the FAK inhibitor narmafotinib The patent extends protection for narmafotinib to at least 2040 [...]
Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares
03/12/2025
Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, Ontario, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced today [...]
Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing
03/12/2025
AGOURA HILLS, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today announced new pharmacokinetic (PK) and tissue-distribution results [...]
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
03/12/2025
Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated [...]
Aeroflow Urology Donates $30,000 to Support Family-Centered Care
03/12/2025
Gifts to Ronald McDonald House and Dementia Society of America® reflect Aeroflow’s continuous commitment to accessible healthcare resources ASHEVILLE, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Aeroflow Urology , a [...]
Wesley Pharmaceuticals Unveils First Product, Zinc Sulfate, Revolutionizing Wellness Solutions
03/12/2025
Debut product from the innovative 503(b) outsourcing facility delivers enhanced wellness to Olympia Pharmaceutical clients, marking a new era of innovation ORLANDO, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Wesley [...]
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
03/12/2025
The minimum condition for the offer has been satisfied, with 184,071,410 shares of CureVac, representing approximately 81.74% of CureVac’s issued and outstanding shares, tendered prior to the expiration of the initial [...]
Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum
03/12/2025
MIAMI, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related [...]
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
03/12/2025
Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the [...]
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
03/12/2025
Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the [...]
BetaGlue Therapeutics étend son essai clinique en Italie après avoir obtenu l’autorisation du ministère de la Santé italien pour mener son étude clinique sur le cancer du pancréas localement avancé non résécable (uLA-PDAC)
03/12/2025
MILAN, 03 déc. 2025 (GLOBE NEWSWIRE) -- BetaGlue ® Therapeutics (« BetaGlue » ou la « Société »), une société d’oncologie en phase clinique développant une solution innovante de radiothérapie pour le traitement ciblé [...]
Elevar Therapeutics Announces Publication of CARES-310 Study Final Analysis in The Lancet Oncology
03/12/2025
Phase 3 trial assessed the efficacy and safety of Elevar’s rivoceranib in combination with camrelizumab as a first-line therapy for uHCC The combination continued to show clinically meaningful survival improvement [...]
Carl H. Sharperson III Joins MATTER Board of Directors
03/12/2025
MINNEAPOLIS, MN , Dec. 03, 2025 (GLOBE NEWSWIRE) -- MATTER, a Minnesota-based global NGO, today announced the appointment of Carl H. Sharperson III to its Board of Directors. Sharperson currently serves as a Senior [...]
NMDP Hires New Philanthropic Leader to Accelerate Financial Giving and Research
03/12/2025
MINNEAPOLIS, Dec. 03, 2025 (GLOBE NEWSWIRE) -- NMDP SM , a global nonprofit leader in cell therapy, hired Jessica Kowal as chief philanthropy officer to lead the NMDP Foundation SM , which expands access to blood stem [...]
4D Path’s Physics-Inspired QPOR™ Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial
03/12/2025
Prospective-trial analysis published in the Journal of the National Cancer Institute predicts residual cancer burden from baseline H&E slides using fully automated, treatment predictive platform NEWTON, Mass., Dec. [...]
MUVON Therapeutics Reports Positive Phase 2 Results for its First-in-Class Muscle Precursor Cell (MPC)-based Tissue-Engineered Therapy Showing Clinically Meaningful and Statistically Significant Benefits in Stress Urinary Incontinence
03/12/2025
Zurich, Switzerland, December 03, 2025 – MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive topline results from the Phase 2 clinical trial SUISSE-MPC2 ( NCT05534269 ) evaluating its novel [...]
Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date
03/12/2025
STAFFORD, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Immuron New U.S. Department of Defense Award & Clinical Trial Update
03/12/2025
Highlights: New US Department of Defense award to develop two new oral therapeutics targeting Campylobacter and Shigella Uniformed Services University P2TD clinical study update MELBOURNE, Australia, Dec. 03, 2025 ( [...]

Pages